Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer
Clinical trial NCT02088684 · COMPLETED
Trial details
- NCT number
- NCT02088684
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-19
- Primary completion
- 2018-04-17
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.